If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Director/PDMR Shareholding

31 Mar 2010 17:17

RNS Number : 5716J
Deltex Medical Group PLC
31 March 2010
 



31 March 2010

Deltex Medical Group plc

("Deltex Medical" or the "Company")

 

Director/PDMR Shareholding

 

Deltex Medical Group plc has today been informed that, on 31 March 2010, Nigel J Keen, Chairman of Deltex Medical, transferred 1,446,446 ordinary shares of 2p each in the Company (the "Shares") at 11.625p each into the name of Nigel J Keen and Caroline J Keen, trustees of the Imperialise Pension Fund.

 

The beneficial interest of the aforementioned director in the Shares remains unchanged.

 

For further information please contact:

 

Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman Ewan Phillips, Chief Executive Paul Mitchell, Finance Director

Nominated Adviser and Broker 0207 614 5917

Arden Partners plc 

Christopher Hardie

Matthew Armitt

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRVRILVII
Date   Source Headline
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20167:00 amRNSTwo new US platform programme accounts opened
10th Mar 20167:00 amRNSPlacing and Issue of Shares
2nd Mar 20161:01 pmRNSHolding(s) in Company
25th Feb 201611:00 amRNSResult of General Meeting
23rd Feb 20167:00 amRNSResult of the Open Offer
8th Feb 20167:00 amRNSPosting of Circular
3rd Feb 20167:00 amRNSPlacing and issue of new convertible loan notes
27th Jan 20167:00 amRNSNew US platform programme account opened
27th Jan 20167:00 amRNSTrading Update
9th Dec 20157:00 amRNSTwo new US platform programme accounts opened
23rd Nov 20157:00 amRNSTwo new US platform programme accounts opened
20th Nov 20157:00 amRNSUS fluid variation study published by Premier
18th Nov 20157:00 amRNSOpen access e-learning courses launched
12th Nov 20157:00 amRNSNew US Platform Programme Account Opened
16th Sep 20157:00 amRNSInterim Results
9th Sep 20157:00 amRNSNew US platform programme account opened
21st Aug 201510:40 amRNSHolding(s) in Company
29th Jul 20157:00 amRNSFDA approves paediatric probes for launch in USA
28th Jul 20151:40 pmRNSAdditional Listing
14th Jul 20157:00 amRNSPre-close Trading Update
14th Jul 20157:00 amRNSCanadian tender won
1st Jul 20154:45 pmRNSDirector/PDMR Shareholding
30th Jun 20157:00 amRNSNew US platform programme account opened
24th Jun 20157:00 amRNSNew UK Government R&D funding secured
23rd Jun 20158:00 amRNSAdditional Listing
23rd Jun 20157:00 amRNSDeltex appoints new Group Finance Director
15th Jun 20157:00 amRNSGrant of options
12th Jun 20151:58 pmRNSHolding(s) in Company
9th Jun 20157:00 amRNSLeading US hospital improves surgical outcomes
2nd Jun 20157:00 amRNSBoard Changes
22nd May 201510:25 amRNSDirector Shareholding
12th May 20151:01 pmRNSResult of AGM
6th May 20158:00 amRNSDirectors' Shareholdings/Issue of equity
6th May 20157:02 amRNSFirst US 'remote training' account

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.